Lenvaxen 10 Mg (Lenvatinib) – 30 Capsules

Lenvaxen 10 Mg (Lenvatinib) is an oral receptor tyrosine kinase inhibitor used in the treatment of thyroid cancer. Lenvaxen, the active ingredient in Lenvatinib, is a multitargeted tyrosine kinase inhibitor, reshaping the landscape of cancer care. It is also used for advanced liver cancer that cannot be removed through surgery and has not been previously treated with other medications. This targeted mechanism positions lenvaxen 10 mg as a transformative asset in the treatment of various malignancies.

Lenvaxen 10 mg is primarily prescribed for:

• Thyroid Cancer: Recommended for the treatment of differentiated thyroid cancer that is refractory to radioactive iodine.
• Renal Cell Carcinoma: Indicated for the treatment of advanced renal cell carcinoma, particularly in individuals who have received prior anti-angiogenic therapy.
• Hepatocellular Carcinoma: Used in combination with another medication for the first-line treatment of unresectable hepatocellular carcinoma.

Product Feature:

Essential medications for Thyroid Cancer, Renal Cell Carcinoma, such as Lenvaxen 10 Mg (Lenvatinib), can be procured from Unit Pharmacy!